Sanofi Stock Screener | Share Price & Fundamental Analysis

SANOFI Pharmaceuticals
Screen Sanofi share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹4172.50
▼ -18.70 (-0.45%)
2026-01-06 00:00:00
Share Price BSE
₹4178.55
▼ -12.10 (-0.29%)
2026-01-06 00:00:00
Market Cap ₹9,446.70 Cr.
P/B Ratio 10.95
EPS (TTM) ₹179.46
Dividend Yield 2.85%
Debt to Equity 0.02
52W High ₹6569.50
52W Low ₹4057.00
Operating Margin 32.00%
Profit Margin 22.26%
Revenue (TTM) ₹539.00
EBITDA ₹175.00
Net Income ₹120.00
Total Assets ₹1,612.00
Total Equity ₹861.00

Sanofi Share Price History - Stock Screener Chart

Screen SANOFI historical share price movements with interactive charts. Analyze price trends and patterns.

Sanofi Company Profile - Fundamental Screener

Screen Sanofi company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SANOFI shares.
Sanofi India Limited is a pharmaceutical company primarily engaged in manufacturing and trading drugs and pharmaceuticals. It operates manufacturing facilities in Goa and Ankleshwar, Gujarat, and sells products through independent distributors mainly in India. The company focuses on five therapeutic areas: diabetes, epilepsy, cardiology, allergy, and pain care. Key products include Lantus (insulin), Combiflam (pain relief), Amaryl (anti-diabetic), Allegra (allergy), Cardace (cardiovascular), and Toujeo (long-acting insulin). Sanofi India is majority-owned by Sanofi and its subsidiary Hoechst GmbH, holding 60.37% of its paid-up share capital. The company has undergone several name changes and acquisitions, including the purchase of Universal Medicare's nutraceutical business in 2011. In 2021, Sanofi India sold its Nutraceuticals business to Universal Nutriscience Private Limited, and in 2022-23, its Consumer Healthcare Business was demerged into a wholly-owned subsidiary.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
Chairperson/CEO Aditya Narayan
ISIN INE058A01010

Sanofi Balance Sheet Screener - Fundamental Analysis

Fair Value Analysis
Screen SANOFI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2024 2023
Assets
Total Assets 1,612 1,715
Current Assets 1,127 1,248
Fixed Assets 313 315
Liabilities
Total Liabilities 1,612 1,715
Current Liabilities 32 48
Non-Current Liabilities 0 0
Shareholders' Equity
Total Equity 861 1,015
Share Capital 23 23
Reserves & Surplus 838 992
Screen SANOFI income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
Item 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar
Revenue 539 529 526 503 579 547 573 572 622
Expenses 364 397 404 367 400 370 377 393 368
EBITDA 175 132 122 137 179 177 195 179 254
Operating Profit % 32.00% 23.00% 23.00% 21.00% 22.00% 21.00% 23.00% 24.00% 29.00%
Depreciation 10 10 9 9 9 9 9 9 9
Interest 0 0 0 0 0 0 0 1 0
Profit Before Tax 165 122 113 127 169 167 186 169 244
Tax 46 31 30 24 33 30 34 46 54
Net Profit 120 91 82 103 137 138 152 123 190
EPS 51.89 39.64 35.69 44.81 59.31 59.79 65.95 53.37 82.78

Sanofi Cash Flow Screener - Liquidity Fundamentals

Screen SANOFI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2024-March 2023-March
Operating Activities 462 230
Investing Activities -180 38
Financing Activities -392 -878
Net Cash Flow -111 -610
Screen SANOFI shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar
Promoter Holding 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40%
FII Holding 5.57% 5.61% 5.57% 6.11% 5.81% 5.78% 5.63% 0.00%
DII Holding 23.02% 23.06% 22.29% 23.08% 22.79% 22.82% 22.93% 19.47%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 8.38% 8.33% 9.08% 7.97% 8.31% 8.21% 8.33% 9.29%
Other Holding 2.63% 2.61% 2.67% 2.44% 2.69% 2.79% 2.70% 10.85%
Shareholder Count 68,196 66,790 71,395 61,849 67,662 66,211 66,401 76,694

Sanofi Dividend Screener - Share Yield Analysis

Screen SANOFI dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹117.00 2.04%
2023-March ₹167.00 2.06%
2022-March ₹570.00 10.15%
2021-March ₹490.00 6.53%
2020-March ₹365.00 4.63%
2019-March ₹349.00 5.58%
2018-March ₹84.00 1.44%
2017-March ₹71.00 1.37%

Sanofi Index Membership - Market Screener Classification

Screen SANOFI by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.

Sanofi Market Events Screener - Corporate Actions

Screen SANOFI market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
Announcement Date Record Date Event Type Information Price Impact
2025-11-07 2025-11-07 Dividend ₹ 75.00 /share -0.03%
2025-10-29 2025-10-29 Quarterly Result Announcement NA -0.56%
2025-07-31 2025-07-31 Quarterly Result Announcement NA -1.24%
2025-05-15 2025-05-15 Annual General Meeting NA 8.52%
2025-05-14 2025-05-14 Quarterly Result Announcement NA 3.02%
2025-04-25 2025-04-25 Dividend ₹ 117.00 /share 29.86%
2025-02-27 2025-02-27 Quarterly Result Announcement NA -5.58%
2024-11-07 2024-11-07 Quarterly Result Announcement NA -6.28%
2024-05-14 2024-05-14 Annual General Meeting NA -13.18%
2024-05-03 2024-05-03 Dividend ₹ 117.00 /share -5.75%
2024-03-07 2024-03-07 Dividend ₹ 50.00 /share -7.37%
2023-12-18 2023-12-18 Extraordinary General Meeting NA 3.21%
2023-05-11 2023-05-11 Annual General Meeting NA 5.58%
2023-04-28 2023-04-29 Dividend ₹ 183.00 /share 3.20%
2023-04-28 2023-04-29 Dividend ₹ 194.00 /share 3.20%

Sanofi Competitors Screener - Peer Comparison

Screen SANOFI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 413,981 39.37 54,729 9.71% 10,980 39.47
Divis Laboratories 168,254 67.76 9,712 18.67% 2,191 44.14
Torrent Pharmaceuticals 130,251 60.85 11,539 6.99% 1,911 62.90
Cipla 121,731 22.30 28,410 7.12% 5,291 46.90
Dr Reddys Laboratories 103,678 18.24 33,741 16.73% 5,725 43.77
Lupin 96,220 22.10 22,910 13.74% 3,306 55.44
Zydus Life Science 91,940 18.30 23,511 18.55% 4,615 44.07
Mankind Pharma 89,818 50.34 12,744 20.90% 2,007 44.20
Aurobindo Pharma 69,929 20.25 32,346 9.43% 3,484 49.09
Alkem Laboratories 65,498 27.11 13,458 3.70% 2,216 38.49

Sanofi Company Announcements - News Screener

Screen SANOFI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-01-05 Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 View
2026-01-01 Closure of Trading Window View
2026-01-01 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-12-30 Please Find Enclosed Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 View
2025-12-28 Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 View
2025-12-20 Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 View
2025-12-18 Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot View
2025-12-18 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report View
2025-11-18 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-11-17 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot View
2025-11-04 Announcement under Regulation 30 (LODR)-Earnings Call Transcript View
2025-10-31 Intimation Of Record Date View
2025-10-30 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome View
2025-10-30 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-10-29 Announcement under Regulation 30 (LODR)-Investor Presentation View
2025-10-29 Announcement under Regulation 30 (LODR)-Dividend Updates View
2025-10-29 Financial Results For The Quarter And Nine Months Ended 30Th September 2025 View
2025-10-29 Board Meeting Outcome for Financials Results For The Quarter Ended 30Th September 2025 And Recommendation Of Interim Dividend View
2025-10-27 Announcement under Regulation 30 (LODR)-Press Release / Media Release View
2025-10-27 Announcement under Regulation 30 (LODR)-Cessation View